Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cortex regains all Ampakine assets and rights for respiratory depression

March 17, 2011

Human Genome Sciences acquires rights to anticancer drug FP-1039 from FivePrime

March 17, 2011

Epistem and sanofi-aventis enter oncology biomarker collaboration

March 17, 2011

Genfit and sanofi-aventis sign new agreement to develop drugs for metabolic disorders

March 17, 2011

Cleveland Clinic grants Apeiron option to license SHP-1 inhibitors

March 16, 2011

Pluristem Therapeutics and NYU Medical Center partner to treat diabetic foot ulcers

March 16, 2011

Boehringer Ingelheim obtains rights to Acuform technology and Glumetza data

March 16, 2011

Seattle Genetics and Millennium extend antibody-drug conjugate agreement

March 16, 2011

Meiji Seika and RaQualia enter into license agreement for ziprasidone in Japan

March 15, 2011

ChronTech initiates phase IIb trial of its HCV DNA vaccine with Inovio's MedPulser delivery device

March 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...